Analystreport

Kiniksa Pharmaceuticals International (KNSA) had its price target raised by Wedbush from $53.00 to $58.00. They now have an "outperform" rating on the stock.

Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares  (KNSA) 
Last kiniksa pharmaceuticals international, plc - class a ordinary shares earnings: 8/12 04:02 pm Check Earnings Report